Phase 1 Lymphoproliferative Disorders Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders

Epstein-Barr Virus-Associated Lymphoproliferative DisordersEBV-Positive Lymphoma

Daihong Liu18 enrolled1 locationNCT07450391

Recruiting

Phase 1

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NeoplasmsMultiple MyelomaCardiovascular Diseases+11 more

OriCell Therapeutics Co., Ltd.81 enrolled1 locationNCT06271252